[go: up one dir, main page]

NO991164L - Farmas°ytisk preparat for behandling av virussykdommer - Google Patents

Farmas°ytisk preparat for behandling av virussykdommer

Info

Publication number
NO991164L
NO991164L NO991164A NO991164A NO991164L NO 991164 L NO991164 L NO 991164L NO 991164 A NO991164 A NO 991164A NO 991164 A NO991164 A NO 991164A NO 991164 L NO991164 L NO 991164L
Authority
NO
Norway
Prior art keywords
treatment
viral diseases
surface preparation
pharmaceutical surface
pharmaceutical
Prior art date
Application number
NO991164A
Other languages
English (en)
Other versions
NO991164D0 (no
Inventor
Brigitte Koenig
Jean-Pierre Rihoux
Wolfgang Koenig
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO991164L publication Critical patent/NO991164L/no
Publication of NO991164D0 publication Critical patent/NO991164D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Anvendelse av 2-[2-[4-[(4- klorfenyl)fenylmetyl]-1- piperazinyl]etoksy]-eddiksyre, en spesiell optisk isomer eller et farmasøytisk akseptabelt salt av denne som en aktiv ingrediens for fremstillingen av et farmasøytisk preparat for behandling av sykdommer indusert av respiratorisk syncytialvirus.
NO991164A 1996-09-11 1999-03-10 Farmas°ytisk preparat for behandling av virussykdommer NO991164D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96870114 1996-09-11
PCT/EP1997/004859 WO1998010764A1 (en) 1996-09-11 1997-09-08 Pharmaceutical composition for treating viral diseases

Publications (2)

Publication Number Publication Date
NO991164L true NO991164L (no) 1999-03-10
NO991164D0 NO991164D0 (no) 1999-03-10

Family

ID=8226163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991164A NO991164D0 (no) 1996-09-11 1999-03-10 Farmas°ytisk preparat for behandling av virussykdommer

Country Status (23)

Country Link
US (1) US6413970B1 (no)
EP (1) EP0936909A1 (no)
JP (1) JP2001500143A (no)
KR (1) KR20000036025A (no)
CN (1) CN1230116A (no)
AP (1) AP9901474A0 (no)
AR (1) AR009756A1 (no)
AU (1) AU717354B2 (no)
BR (1) BR9712033A (no)
CA (1) CA2265542A1 (no)
CZ (1) CZ83099A3 (no)
EA (1) EA001262B1 (no)
HU (1) HUP9904173A3 (no)
ID (1) ID21369A (no)
IL (1) IL128351A0 (no)
NO (1) NO991164D0 (no)
NZ (1) NZ334571A (no)
OA (1) OA10993A (no)
PE (1) PE107598A1 (no)
PL (1) PL332316A1 (no)
TR (1) TR199900523T2 (no)
WO (1) WO1998010764A1 (no)
ZA (1) ZA977874B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324242A (en) * 1997-04-18 1998-10-21 Atindra Nath Chakrabarty Medicaments for treating viral infections
BR0011997A (pt) 1999-06-28 2002-03-05 Janssen Pharmaceutica Nv Inibidores da replicação do vìrus sincicial respiratório
CN1210275C (zh) 1999-06-28 2005-07-13 詹森药业有限公司 呼吸道合胞病毒复制抑制剂
EP1418175A1 (en) 1999-06-28 2004-05-12 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
ATE386526T1 (de) * 2002-07-02 2008-03-15 Ucb Farchim Sa Diarylmethylpiperazines als prophylaktische oder therapeutische mittel gegen virale myocarditis
WO2004050647A2 (en) * 2002-12-04 2004-06-17 Dr. Reddy's Laboratories Limited Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
CN102988346A (zh) * 2012-11-19 2013-03-27 何晓涛 Aphanamixoid A在抗呼吸道合胞病毒的药物中的应用
CN103356650A (zh) * 2013-07-04 2013-10-23 丁圣雨 Chukrasone A在抗呼吸道合胞病毒的药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.

Also Published As

Publication number Publication date
WO1998010764A1 (en) 1998-03-19
CZ83099A3 (cs) 1999-06-16
CN1230116A (zh) 1999-09-29
ID21369A (id) 1999-05-27
BR9712033A (pt) 2000-01-18
TR199900523T2 (xx) 1999-05-21
PE107598A1 (es) 1999-01-29
KR20000036025A (ko) 2000-06-26
AU717354B2 (en) 2000-03-23
EP0936909A1 (en) 1999-08-25
AP9901474A0 (en) 1999-03-31
HUP9904173A2 (hu) 2000-05-28
IL128351A0 (en) 2000-01-31
HUP9904173A3 (en) 2001-04-28
EA199900226A1 (ru) 1999-08-26
NZ334571A (en) 2000-10-27
US6413970B1 (en) 2002-07-02
PL332316A1 (en) 1999-08-30
JP2001500143A (ja) 2001-01-09
AU4621397A (en) 1998-04-02
ZA977874B (en) 1999-03-02
AR009756A1 (es) 2000-05-03
OA10993A (fr) 2003-03-04
NO991164D0 (no) 1999-03-10
EA001262B1 (ru) 2000-12-25
CA2265542A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
NO20001417L (no) Farmasøytisk preparat omfattende klodronat som aktiv bestanddel samt silisifiert mikrokrystallinsk cellulose som eksipient
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
HUP0101580A2 (hu) Gélesedő gyógyászati készítmények
IL155919A (en) (e) - 7 - [4 - (4 - fluorophenyl) - 6 - isopropyl - 2 - [methyl ( methylsulfonyl) amino] pyrimidin - 5 - yl] (3r, 5s) - dihydroxyhept - 6 - enoic acid, or a pharmaceutically acceptable salt thereof, for use as a medicament for the treatment of heterozygous familial hypercholesterolemia
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
NO2012019I1 (no) Kombinasjon av flutikason og formoterol, eller hvilket som helst farmasøytisk akseptabelt salt ellerderivat derav som er beskyttet ved basispatentet, inkludert kombinasjonen av flutikasonpropionat og formoterolfumarat.
DK0552256T3 (da) Fremgangsmåde til at behandle eller forebygge type 1 diabetes ved peroral indgivelse af insulin
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
DE60114635D1 (de) Pharmazeutische formulierungen
NO20060991L (no) Feksofenadinsammensetning og fremgangsmate til fremstilling
NO991164L (no) Farmas°ytisk preparat for behandling av virussykdommer
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
PA8426801A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis.
NO20022591L (no) Finmalt form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}etoksy)fenyl]propansyre
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
BR0309014A (pt) ácido(2-((2-alcóxi)-fenil)-ciclopent-1-enil)carbo e heterocìclico aromático e derivados
NO883468D0 (no) Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere ved applikasjon paa slimhuden.
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
BR0209985A (pt) Composto e método para o tratamento de um paciente
EP1062948A4 (en) DRUGS AGAINST CARDIAC DIASTOLIC DISORDERS
WO2002017917A8 (en) Manzamines for treatment of drug resistant infection
AU2003249881A1 (en) Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application